We spoke with Oliver Horn, CEO of Elixinol Global, on the company’s opportunities in over-the-counter CBD-based products in the cannabis space. And on the company’s recent acquisition in German, the liberal regulatory environment in which Elixinol operates and the current turnaround plan for the company.
Read the most recent article on EXL here
